Emerging roles of protein deamidation in innate immune signaling

Journal of Virology

Volumn 90, Issue 9, 2016, Pages 4262-4268

  Zhao, Jun ^a   Li, Junhua ^a   Xu, Simin ^a   Feng, Pinghui ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDASE; ASPARAGINE; CYTOKINE; ENZYME; GLUTAMINE; GLUTAMINE AMIDOTRANSFERASE; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG; PATTERN RECOGNITION RECEPTOR; PROTEIN; RETINOIC ACID RECEPTOR;

ARTICLE; BNRF1 GENE; CYTOKINE PRODUCTION; DEAMINATION; DNA DAMAGE; DNA VIRUS; ENZYME ACTIVE SITE; EPSTEIN BARR VIRUS; GAMMAHERPESVIRINAE; GAMMAHERPESVIRUS 68; INNATE IMMUNITY; KSHV GENE; MAMMAL CELL; MAVS GENE; MOLECULAR INTERACTION; NONHUMAN; ORF3 GENE; ORF75 GENE; ORF75C GENE; PRIORITY JOURNAL; PROTEIN DEAMINATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RNA VIRUS; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; VIRUS CELL INTERACTION; VIRUS GENE; VIRUS GENOME; VIRUS INFECTION; ANIMAL; BIOSYNTHESIS; CATALYSIS; HOST PATHOGEN INTERACTION; HUMAN; IMMUNE EVASION; METABOLISM; PROTEIN DEGRADATION;

ANIMALS; CATALYSIS; CYTOKINES; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; PROTEINS; PROTEOLYSIS; RECEPTORS, PATTERN RECOGNITION; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION;

EID: 84964928607     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01980-15     Document Type: Article

References (70)

1. Takeuchi O, Akira S. 2010. Pattern recognition receptors and inflammation. Cell 140:805-820. http://dx.doi.org/10.1016/j.cell.2010.01.022.
2. Hornung V, Ellegast J, Kim S, Brzozka K, Jung A, Kato H, Poeck H, Akira S, Conzelmann KK, Schlee M, Endres S, Hartmann G. 2006. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314:994-997. http://dx.doi.org/10.1126/science.1132505.
3. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh CS, Reise Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
4. Pichlmair A, Schulz O, Tan CP, Naslund TI, Liljestrom P, Weber F, Reise Sousa C. 2006. RIG-I-mediated antiviral responses to singlestranded RNA bearing 5'-phosphates. Science 314:997-1001. http://dx.doi.org/10.1126/science.1132998.
5. Schmidt A, Schwerd T, Hamm W, Hellmuth JC, Cui S, Wenzel M, Hoffmann FS, Michallet MC, Besch R, Hopfner KP, Endres S, Rothenfusser S. 2009. 5'-triphosphate RNA requires base-paired structures to activate antiviral signaling via RIG-I. Proc Natl Acad SciUSA106:12067-12072 http://dx.doi.org/10.1073/pnas.0900971106.
6. Saito T, Hirai R, Loo YM, Owen D, Johnson CL, Sinha SC, Akira S, Fujita T, Gale M, Jr. 2007. Regulation of innate antiviral defenses through a shared repressor domain in RIG-I and LGP2. Proc Natl Acad Sci U S A 104:582-587. http://dx.doi.org/10.1073/pnas.0606699104.
7. Takahasi K, Yoneyama M, Nishihori T, Hirai R, Kumeta H, Narita R, Gale M, Jr, Inagaki F, Fujita T. 2008. Nonself RNA-sensing mechanism of RIG-I helicase and activation of antiviral immune responses. Mol Cell 29:428-440. http://dx.doi.org/10.1016/j.molcel.2007.11.028.
8. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S. 2011. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147:423-435. http://dx.doi.org/10.1016/j.cell.2011.09.039.
9. Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM. 2011. Structural insights into RNA recognition by RIG-I. Cell 147:409-422. http://dx.doi.org/10.1016/j.cell.2011.09.023.
10. Wu B, Peisley A, Tetrault D, Li Z, Egelman EH, Magor KE, Walz T, Penczek PA, Hur S. 2014. Molecular imprinting as a signal-activation mechanism of the viral RNA sensor RIG-I. Mol Cell 55:511-523. http://dx.doi.org/10.1016/j.molcel.2014.06.010.
11. Fitzgerald KA, McWhirter SM, Faia KL, Rowe DC, Latz E, Golenbock DT, Coyle AJ, Liao SM, Maniatis T. 2003. IKKepsilon and TBK1 are essential components of the IRF3 signaling pathway. Nat Immunol 4:491-496. http://dx.doi.org/10.1038/ni921.
12. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. 2003. Triggering the interferon antiviral response through an IKK-related pathway. Science 300:1148-1151. http://dx.doi.org/10.1126/science.1081315.
13. Hou F, Sun L, Zheng H, Skaug B, Jiang QX, Chen ZJ. 2011. MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response. Cell 146:448-461. http://dx.doi.org/10.1016/j.cell.2011.06.041.
14. Panne D, Maniatis T, Harrison SC. 2007. An atomic model of the interferon-beta enhanceosome. Cell 129:1111-1123. http://dx.doi.org/10.1016/j.cell.2007.05.019.
15. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU. 2007. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446:916-920. http://dx.doi.org/10.1038/nature05732.
16. Zeng W, Sun L, Jiang X, Chen X, Hou F, Adhikari A, Xu M, Chen ZJ. 2010. Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141:315-330. http://dx.doi.org/10.1016/j.cell.2010.03.029.
17. Oshiumi H, Miyashita M, Inoue N, Okabe M, Matsumoto M, Seya T. 2010. The ubiquitin ligase Riplet is essential for RIG-I-dependent innate immune responses to RNA virus infection. Cell Host Microbe 8:496-509. http://dx.doi.org/10.1016/j.chom.2010.11.008.
18. Maharaj NP, Wies E, Stoll A, Gack MU. 2012. Conventional protein kinase C-alpha (PKC-alpha) and PKC-beta negatively regulate RIG-I antiviral signal transduction. J Virol 86:1358-1371. http://dx.doi.org/10.1128/JVI.06543-11.
19. Sun Z, Ren H, Liu Y, Teeling JL, Gu J. 2011. Phosphorylation of RIG-I by casein kinase II inhibits its antiviral response. J Virol 85:1036-1047. http://dx.doi.org/10.1128/JVI.01734-10.
20. Wies E, Wang MK, Maharaj NP, Chen K, Zhou S, Finberg RW, Gack MU. 2013. Dephosphorylation of the RNA sensors RIG-I and MDA5 by the phosphatase PP1 is essential for innate immune signaling. Immunity 38:437-449. http://dx.doi.org/10.1016/j.immuni.2012.11.018.
21. Feng P, Moses A, Fruh K. 2013. Evasion of adaptive and innate immune response mechanisms by gamma-herpesviruses. Curr Opin Virol 3:285-295. http://dx.doi.org/10.1016/j.coviro.2013.05.011.
22. Sparrer KM, Gack MU. 2015. Intracellular detection of viral nucleic acids. Curr Opin Microbiol 26:1-9. http://dx.doi.org/10.1016/j.mib.2015.03.001.
23. Loo YM, Gale M, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34:680-692. http://dx.doi.org/10.1016/j.immuni.2011.05.003.
24. Gack MU, Albrecht RA, Urano T, Inn KS, Huang IC, Carnero E, Farzan M, Inoue S, Jung JU, Garcia-Sastre A. 2009. Influenza A virus NS1 targets the ubiquitin ligase TRIM25 to evade recognition by the host viral RNA sensor RIG-I. Cell Host Microbe 5:439-449. http://dx.doi.org/10.1016/j.chom.2009.04.006.
25. Li XD, Sun L, Seth RB, Pineda G, Chen ZJ. 2005. Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity. Proc Natl Acad Sci U S A 102: 17717-17722. http://dx.doi.org/10.1073/pnas.0508531102.
26. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J. 2005. Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437:1167-1172. http://dx.doi.org/10.1038/nature04193.
27. Li K, Foy E, Ferreon JC, Nakamura M, Ferreon AC, Ikeda M, Ray SC, Gale M, Jr, Lemon SM. 2005. Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF. Proc Natl Acad Sci U S A 102:2992-2997. http://dx.doi.org/10.1073/pnas.0408824102.
28. Chen Z, Benureau Y, Rijnbrand R, Yi J, Wang T, Warter L, Lanford RE, Weinman SA, Lemon SM, Martin A, Li K. 2007. GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS. J Virol 81:964-976. http://dx.doi.org/10.1128/JVI.02076-06.
29. Yang Y, Liang Y, Qu L, Chen Z, Yi M, Li K, Lemon SM. 2007. Disruption of innate immunity due to mitochondrial targeting of a picornaviral protease precursor. Proc Natl Acad Sci U S A 104:7253-7258. http://dx.doi.org/10.1073/pnas.0611506104.
30. Wang B, Xi X, Lei X, Zhang X, Cui S, Wang J, Jin Q, Zhao Z. 2013. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog 9:e1003231. http://dx.doi.org/10.1371/journal.ppat.1003231.
31. Mukherjee A, Morosky SA, Delorme-Axford E, Dybdahl-Sissoko N, Oberste MS, Wang T, Coyne CB. 2011. The coxsackievirus B 3C protease cleaves MAVS and TRIF to attenuate host type I interferon and apoptotic signaling. PLoS Pathog 7:e1001311. http://dx.doi.org/10.1371/journal.ppat.1001311.
32. Dong X, Feng H, Sun Q, Li H, Wu TT, Sun R, Tibbetts SA, Chen ZJ, Feng P. 2010. Murine gamma-herpesvirus 68 hijacks MAVS and IKKbeta to initiate lytic replication. PLoS Pathog 6:e1001001. http://dx.doi.org/10.1371/journal.ppat.1001001.
33. Dong X, Feng P. 2011. Murine gamma herpesvirus 68 hijacks MAVS and IKKbeta to abrogate NFkappaB activation and antiviral cytokine production. PLoS Pathog 7:e1002336. http://dx.doi.org/10.1371/journal.ppat.1002336.
34. Dong X, He Z, Durakoglugil D, Arneson L, Shen Y, Feng P. 2012. Murine gammaherpesvirus 68 evades host cytokine production via replication transactivator-induced RelA degradation. J Virol 86:1930-1941. http://dx.doi.org/10.1128/JVI.06127-11.
35. He S, Zhao J, Song S, He X, Minassian A, Zhou Y, Zhang J, Brulois K, Wang Y, Cabo J, Zandi E, Liang C, Jung JU, Zhang X, Feng P. 2015. Viral pseudo-enzymes activate RIG-I via deamidation to evade cytokine production. Mol Cell 58:134-146. http://dx.doi.org/10.1016/j.molcel.2015.01.036.
36. Ling PD, Tan J, Sewatanon J, Peng R. 2008. Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J Virol 82:8000-8012. http://dx.doi.org/10.1128/JVI.02752-07.
37. Tsai K, Thikmyanova N, Wojcechowskyj JA, Delecluse HJ, Lieberman PM. 2011. EBV tegument protein BNRF1 disrupts DAXX-ATRX to activate viral early gene transcription. PLoS Pathog 7:e1002376. http://dx.doi.org/10.1371/journal.ppat.1002376.
38. Full F, Jungnickl D, Reuter N, Bogner E, Brulois K, Scholz B, Sturzl M, Myoung J, Jung JU, Stamminger T, Ensser A. 2014. Kaposi's sarcoma associated herpesvirus tegument protein ORF75 is essential for viral lytic replication and plays a critical role in the antagonization of ND10-instituted intrinsic immunity. PLoS Pathog 10:e1003863. http://dx.doi.org/10.1371/journal.ppat.1003863.
39. Anand R, Hoskins AA, Stubbe J, Ealick SE. 2004. Domain organization of Salmonella typhimurium formylglycinamide ribonucleotide amidotransferase revealed by X-ray crystallography. Biochemistry 43:10328-10342 http://dx.doi.org/10.1021/bi0491301.
40. Gaspar M, Gill MB, Losing JB, May JS, Stevenson PG. 2008. Multiple functions for ORF75c in murid herpesvirus-4 infection. PLoS One 3:e2781. http://dx.doi.org/10.1371/journal.pone.0002781.
41. Guy HI, Schmidt B, Herve G, Evans DR. 1998. Pressure-induced dissociation of carbamoyl-phosphate synthetase domains. The catalytically active form is dimeric. J Biol Chem 273:14172-14178.
42. Mycek MJ, Waelsch H. 1960. The enzymatic deamidation of proteins. J Biol Chem 235:3513-3517.
43. Robinson NE, Robinson AB. 2001. Prediction of protein deamidation rates from primary and three-dimensional structure. Proc Natl Acad Sci U S A 98:4367-4372. http://dx.doi.org/10.1073/pnas.071066498.
44. Robinson NE, Robinson AB. 2001. Molecular clocks. Proc Natl Acad Sci U S A 98:944-949. http://dx.doi.org/10.1073/pnas.98.3.944.
45. Patterson D, Bleskan J, Gardiner K, Bowersox J. 1999. Human phosphoribosylformylglycineamide amidotransferase (FGARAT): regional mapping, complete coding sequence, isolation of a functional genomic clone, and DNA sequence analysis. Gene 239:381-391. http://dx.doi.org/10.1016/S0378-1119(99)00378-9.
46. Massière F, Badet-Denisot MA. 1998. The mechanism of glutaminedependent amidotransferases. Cell Mol Life Sci 54:205-222. http://dx.doi.org/10.1007/s000180050145.
47. Bonavia A, Franti M, Pusateri Keaney E, Kuhen K, Seepersaud M, Radetich B, Shao J, Honda A, Dewhurst J, Balabanis K, Monroe J, Wolff K, Osborne C, Lanieri L, Hoffmaster K, Amin J, Markovits J, Broome M, Skuba E, Cornella-Taracido I, Joberty G, Bouwmeester T, Hamann L, Tallarico JA, Tommasi R, Compton T, Bushell SM. 2011. Identification of broad-spectrum antiviral compounds and assessment of the druggability of their target for efficacy against respiratory syncytial virus (RSV). Proc Natl Acad Sci U S A 108:6739-6744. http://dx.doi.org/10.1073/pnas.1017142108.
48. Wang QY, Bushell S, Qing M, Xu HY, Bonavia A, Nunes S, Zhou J, Poh MK, Florez de Sessions P, Niyomrattanakit P, Dong H, Hoffmaster K, Goh A, Nilar S, Schul W, Jones S, Kramer L, Compton T, Shi PY. 2011. Inhibition of dengue virus through suppression of host pyrimidine biosynthesis. J Virol 85:6548-6556. http://dx.doi.org/10.1128/JVI.02510-10.
49. Hoffmann HH, Kunz A, Simon VA, Palese P, Shaw ML. 2011. Broadspectrum antiviral that interferes with de novo pyrimidine biosynthesis. Proc Natl Acad Sci U S A 108:5777-5782. http://dx.doi.org/10.1073/pnas.1101143108.
50. Lucas-Hourani M, Dauzonne D, Jorda P, Cousin G, Lupan A, Helynck O, Caignard G, Janvier G, Andre-Leroux G, Khiar S, Escriou N, Despres P, Jacob Y, Munier-Lehmann H, Tangy F, Vidalain PO. 2013. Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity. PLoS Pathog 9:e1003678. http://dx.doi.org/10.1371/journal.ppat.1003678.
51. Goldstone DC, Ennis-Adeniran V, Hedden JJ, Groom HC, Rice GI, Christodoulou E, Walker PA, Kelly G, Haire LF, Yap MW, de Carvalho LP, Stoye JP, Crow YJ, Taylor IA, Webb M. 2011. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480:379-382. http://dx.doi.org/10.1038/nature10623.
52. List F, Vega MC, Razeto A, Hager MC, Sterner R, Wilmanns M. 2012. Catalysis uncoupling in a glutamine amidotransferase bienzyme by unblocking the glutaminase active site. Chem Biol 19:1589-1599. http://dx.doi.org/10.1016/j.chembiol.2012.10.012.
53. Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, Fiorentini C, Boquet P. 1997. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387:729-733. http://dx.doi.org/10.1038/42743.
54. Lerm M, Selzer J, Hoffmeyer A, Rapp UR, Aktories K, Schmidt G. 1999. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun 67:496-503.
55. Sugai M, Hatazaki K, Mogami A, Ohta H, Peres SY, Herault F, Horiguchi Y, Masuda M, Ueno Y, Komatsuzawa H, Suginaka H, Oswald E. 1999. Cytotoxic necrotizing factor type 2 produced by pathogenic Escherichia coli deamidates a gln residue in the conserved G-3 domain of the rho family and preferentially inhibits the GTPase activity of RhoA and rac1. Infect Immun 67:6550-6557.
56. Buetow L, Flatau G, Chiu K, Boquet P, Ghosh P. 2001. Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nat Struct Biol 8:584-588. http://dx.doi.org/10.1038/89610.
57. Chao X, Muff TJ, Park SY, Zhang S, Pollard AM, Ordal GW, Bilwes AM, Crane BR. 2006. A receptor-modifying deamidase in complex with a signaling phosphatase reveals reciprocal regulation. Cell 124:561-571. http://dx.doi.org/10.1016/j.cell.2005.11.046.
58. Cui J, Yao Q, Li S, Ding X, Lu Q, Mao H, Liu L, Zheng N, Chen S, Shao F. 2010. Glutamine deamidation and dysfunction of ubiquitin/NEDD8 induced by a bacterial effector family. Science 329:1215-1218. http://dx.doi.org/10.1126/science.1193844.
59. Sanada T, Kim M, Mimuro H, Suzuki M, Ogawa M, Oyama A, Ashida H, Kobayashi T, Koyama T, Nagai S, Shibata Y, Gohda J, Inoue J, Mizushima T, Sasakawa C. 2012. The Shigella flexneri effector OspI deamidates UBC13 to dampen the inflammatory response. Nature 483: 623-626. http://dx.doi.org/10.1038/nature10894.
60. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, Aktories K. 1997. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387:725-729. http://dx.doi.org/10.1038/42735.
61. Orth JH, Preuss I, Fester I, Schlosser A, Wilson BA, Aktories K. 2009. Pasteurella multocida toxin activation of heterotrimeric G proteins by deamidation. Proc Natl Acad Sci U S A 106:7179-7184. http://dx.doi.org/10.1073/pnas.0900160106.
62. Zhang L, Krachler AM, Broberg CA, Li Y, Mirzaei H, Gilpin CJ, Orth K. 2012. Type III effector VopC mediates invasion for Vibrio species. Cell Rep 1:453-460. http://dx.doi.org/10.1016/j.celrep.2012.04.004.
63. Cruz-Migoni A, Hautbergue GM, Artymiuk PJ, Baker PJ, Bokori-Brown M, Chang CT, Dickman MJ, Essex-Lopresti A, Harding SV, Mahadi NM, Marshall LE, Mobbs GW, Mohamed R, Nathan S, Ngugi SA, Ong C, Ooi WF, Partridge LJ, Phillips HL, Raih MF, Ruzheinikov S, Sarkar-Tyson M, Sedelnikova SE, Smither SJ, Tan P, Titball RW, Wilson SA, Rice DW. 2011. A Burkholderia pseudomallei toxin inhibits helicase activity of translation factor eIF4A. Science 334:821-824. http://dx.doi.org/10.1126/science.1211915.
64. Deverman BE, Cook BL, Manson SR, Niederhoff RA, Langer EM, Rosova I, Kulans LA, Fu X, Weinberg JS, Heinecke JW, Roth KA, Weintraub SJ. 2002. Bcl-xL deamidation is a critical switch in the regulation of the response toDNAdamage. Cell 111:51-62. http://dx.doi.org/10.1016/S0092-8674(02)00972-8.
65. Molberg O, McAdam SN, Korner R, Quarsten H, Kristiansen C, Madsen L, Fugger L, Scott H, Noren O, Roepstorff P, Lundin KE, Sjostrom H, Sollid LM. 1998. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 4:713-717. http://dx.doi.org/10.1038/nm0698-713.
66. Wang H, Piatkov KI, Brower CS, Varshavsky A. 2009. Glutaminespecific N-terminal amidase, a component of the N-end rule pathway. Mol Cell 34:686-695. http://dx.doi.org/10.1016/j.molcel.2009.04.032.
67. Bidinosti M, Ran I, Sanchez-Carbente MR, Martineau Y, Gingras AC, Gkogkas C, Raught B, Bramham CR, Sossin WS, Costa-Mattioli M, DesGroseillers L, Lacaille JC, Sonenberg N. 2010. Postnatal deamidation of 4E-BP2 in brain enhances its association with raptor and alters kinetics of excitatory synaptic transmission. Mol Cell 37:797-808. http://dx.doi.org/10.1016/j.molcel.2010.02.022.
68. Washington EJ, Banfield MJ, Dangl JL. 2013. What a difference a Dalton makes: bacterial virulence factors modulate eukaryotic host cell signaling systems via deamidation. Microbiol Mol Biol Rev 77:527-539. http://dx.doi.org/10.1128/MMBR.00013-13.
69. Weintraub SJ, Deverman BE. 2007. Chronoregulation by asparagine deamidation. Sci STKE 2007:re7.
70. Tsai K, Messick TE, Lieberman PM. 2015. Disruption of host antiviral resistances by gammaherpesvirus tegument proteins with homology to the FGARAT purine biosynthesis enzyme. Curr Opin Virol 14:30-40. http://dx.doi.org/10.1016/j.coviro.2015.07.008.